- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- boltz.bio
- Last Round
- SeedJan 2026
- Rounds
- 1
About
Public benefit company building open-source biomolecular AI models and a hosted platform for drug discovery researchers and biotech teams.
Summary
Boltz is an Artificial Intelligence company based in Cambridge, United States. Its most recent funding was a Seed round in Jan 2026. Investors include Amplify Partners, Andreessen Horowitz and Zetta Venture Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Investors
.png){kind=avatar}
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.